UNC faculty and trainees to present at the world’s largest clinical cancer research meeting

The American Society of Clinical Oncology’s annual meeting in Chicago, taking place May 30 – June 3, will bring together more than 40,000 oncology professionals in person and virtually. This year’s theme is “Driving Knowledge to Action: Building a Better Future.”

Faculty and trainees from UNC Lineberger and UNC will share their latest research findings and clinical insights during talks, poster presentations and panel discussions during the meeting.

The UNC presentations include:

Friday, May 30

Oral Abstract Session

1 – 4 p.m. CT  |  S504

Care Delivery and Quality Care

Too Many Rules, Too Many Traps: Can Policy Help Close the Gaps?

Panelist: Mya Roberson, PhD, MSPH

---

Rapid Oral Abstract Session

Breast Cancer

2:45 – 4:15 p.m. CT  |  Hall D2

Co-chair: Yara Abdou, MD

---

Saturday, May 31

Poster Session

1:30 – 4:30 p.m. CT  |  Hall A

Care Delivery and Quality Care

(Poster 417) Association between cost and insurance on receipt of guideline-concordant mammography. (Abstract 11078)

Presenter: Nicole E. Caston, PhD, MPH

 

(Poster 433) Preliminary efficacy of VOICE, a decision support tool for older adults with advanced cancer: A pilot randomized trial. (Abstract 11094)

Presenter: Daniel Richardson, MD, MSc, MA

 

(Poster 477) OncoPRO: A US national initiative supporting implementation of remote symptom monitoring with electronic patient-reported outcomes (ePROs) in oncology practices. (Abstract 11138)

Presenter: Ethan Basch, MD, MSc, FASCO

---

Sunday, June 1

Poster Session

9 a.m. – 12 p.m.  |  Hall A

Care Delivery and Quality Care

(Poster 277) Integrating collaborative care in oncology: Improving quality of life and mental health for patients with cancer. (Abstract 1524)

Presenter: Kyle Lavin, MD, MPH

 

(Poster 284) Implementation of an academic precision oncology service in a community setting. (Abstract 1531)

 Presenter: Junlone Moy, PharmD, RPh

---

Rapid Oral Abstract Session

4:30 – 6:30 p.m. CT  |  S402

Care Delivery and Quality Care

5:06 – 5:12 p.m. CT: Treatment preferences between survival and quality of life and their association with clinical outcomes in older adults with advanced cancer. (Abstract 11013)

Presenter: Daniel Richardson, MD, MSc, MA

---

Monday, June 2

Case-Based Panel

8 – 9 a.m. CT |  Hall B1

Genitourinary Cancer — Kidney and Bladder

From Localized to Metastatic: Navigating the Renal Cell Carcinoma Treatment Landscape

Medical Oncologist Perspective: Catherine Fahey, MD, PhD

---

Poster Session

9 a.m. – 12 p.m. CT |  Hall A

Breast Cancer—Local/Regional/Adjuvant

(Poster 120) Real-world (RW) analysis of characteristics and risk of recurrence (ROR) in Black patients (pts) with HR+/HER2− early breast cancer (EBC) eligible for NATALEE. (Abstract 527)

Presenter: Yara Abou, MD

---

Poster Session

9 a.m. – 12 p.m. CT  |  Hall A

Genitourinary Cancer — Kidney and Bladder

(Poster 403) Pathologic response and safety of neoadjuvant pembrolizumab with or without entinostat in muscle-invasive urothelial cancer (MIUC). (Abstract 4603)

Presenter: Tracy Rose, MD, MPH

 

Head and Neck Cancer

(Poster 445) Versatile-002: Overall survival of HPV16-positive recurrent/metastatic head and neck squamous cell carcinoma patients treated with T cell stimulating immunotherapy PDS0101 and pembrolizumab. (Abstract 6037)

 Presenter: Jared Weiss, MD

---

Oral Abstract Session

3 – 6 p.m. CT  |  Hall B1

Breast Cancer—Local/Regional/Adjuvant

5:12 – 5:24 p.m. CT: The impact of ovarian function suppression with adjuvant endocrine therapy on survival outcomes in young germline BRCA mutation carriers with breast cancer: Secondary analysis of an international cohort study. (Abstract 507)

5:48 – 6 p.m. CT: Panel Q&A

Presenter: Paola Zagami, MD

---

Publication-Only

Pharmacologic and pharmacometric studies of factors affecting the pharmacokinetics and pharmacodynamics of antibody drug conjugate anetumab ravtansine in patients with solid tumors.(Abstract: e15024)

Li Chen, PharmD

 

Risk of acute care events: Designing prognostic models for real world use. (Abstract e13562)

Jennifer Elston Lafata, PhD

 

An 8-year single institution review of demographic trends and treatment patterns among patients with anaplastic thyroid carcinoma. (Abstract e18139)

Makayla Matthews

 

Optimizing evidence-based, patient-centered care in bladder cancer in community-based settings: A Project ECHO initiative. (Abstract e16607)

Matthew I. Milowsky, MD, FASCO